Landscape analysis: A look at the regulation of decentralized trials and what’s coming soon
In the past few years, regulators and researchers have shown increased interest in leveraging decentralized trial methods – especially following the pandemic. In this article, AgencyIQ explores the current regulatory state of decentralized trials and what’s likely coming next.
Decentralized clinical trials (DCTs) employ technologies to remotely communicate with study participants and collect clinical data. Study participants may complete some trial activities from sites other than those located at a traditional, centralized trial site model.
Fill out the form to read the full article.
Required *